article thumbnail

Some Talc Products Contain Asbestos: Study

The Pharma Data

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. She noted that EWG’s online database has identified more than 2,000 personal care products that contain talc, including more than 1,000 loose or pressed powders that could pose an inhalation risk. MONDAY, Nov. © 2020 HealthDay.

article thumbnail

BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US

XTalks

BONESUPPORT has recently received market authorization from the US Food and Drug Administration (FDA) for Cerament G, its bone graft with antibiotic elution. Xtalks learned more about BONESUPPORT and its first FDA-approved drug-device combination product Cerament G through an email interview with BONESUPPORT’s CEO Emil Billbäck.

Filler 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Section 804 Drug Import Rule Does Not Allow Foreign Versions of FDA-Approved Drugs

Pharmacy Checkers

The new federal rule on drug importation from Canada , drafted pursuant to Section 804 of the FDCA, does not allow for the importation of foreign versions of FDA-approved drugs. It only allows for the importation of FDA-approved drugs. Prescription Drug Importation.” Bollyky and Aaron S. to $750 a pill overnight.

article thumbnail

Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine

The Pharma Data

Novartis blazoned moment that it has inked an original agreement to work its manufacturing capacity and capabilities to address the COVID-19 epidemic by expanding its support of the filler and finish of the Pfizer-BioNTech COVID-19 vaccine. About Novartis Novartis is reimagining drug to ameliorate and extend people’s lives.

article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

. Juyou will be responsible for the overall clinical development and regulatory filings for Pliaglis with the National Medical Products Administration (the “NMPA”, formerly the China State Food and Drug Administration). million and US$1.8 million. . Juyou Bio-Technology Co.,

article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

We see the dedication of healthcare workers – or of the shelf-filler in our local store – and we are moved to thank them and to make our own contribution. Bourla made Pfizer’s manufacturing capabilities available to small biotech concerns and is in talks to make large quantities of other companies’ COVID-19 drug candidates.

article thumbnail

Microparticle analysis: methods and uses in the pharmaceutical industry

Pharmaceutical Technology

Most molecules absorb light in the IR region of the electromagnetic spectrum, converting it to molecular vibration, and this absorption characterises the nature of the chemical bonds contained in a sample. Bruker Optics’ HYPERION II removes this limitation and enables both IR laser imaging and μ-FT-IR to be carried out using one system.